Scleroderma Support: Patients Find Help Online
Dinesh Khanna, MD, MSc, develops website to help patients with scleroderma learn about their condition and how to manage symptoms and advocate for themselves.
Dinesh Khanna, MD, MSc, develops website to help patients with scleroderma learn about their condition and how to manage symptoms and advocate for themselves.
M-RISE team members, Brahmajee Nallamothu, MD, MPH, and David Pinsky, MD, to lead one of three research projects and the postdoctoral training program.
Devraj Sukul, MD, finds that despite doctor's efforts to increase referrals for cardiac rehab, patients' enrollment remains low.
Findings from the U-M National Poll on Healthy Aging, conducted by the IHPI and supported by AARP and Michigan Medicine, feed papers, presentations, and academic blog posts.
Neil Alexander, MD, MS, is recognized by the Gerontological Society of America with the Excellence in Rehabilitation of Aging Persons Award.
Luis Villacorta, PhD, identifies a potential treatment for non-alcoholic fatty liver disease.
Thomas Sisson, MD, comments on the benefits of exercise in patients with cystic fibrosis.
Mary AM Rogers, PhD, MS, finds that type 1 diabetes rates were one-third lower in children who received all doses of the rotavirus vaccine.
Congratulations to this year's Department of Internal Medicine awardees!
William Chey, MD, explains key findings and takeaways from his recent study evaluating the effectiveness, safety, and tolerability of FDgard in patients with functional dyspepsia.
Gregory Kalemkerian, MD, discusses first-line treatment for extensive-stage small-cell lung cancer and the recent FDA approval of atezolizumab.
Sarah Krein, PhD, RN, will be honored with the Distinguished Scientist Award at the Association for Professionals in Infection Control and Epidemiology 46th Annual Conference.
Kevin Flaherty, MD, MS, comments on the significant value that the Pulmonary Fibrosis Foundation Patient Registry brings to pulmonary fibrosis research.
Thomas Valley, MD, MSc, finds intensive care is still the right option for some vulnerable patients after a severe heart attack.
David Paje, MD, finds that the use of peripherally inserted central catheters is common in hospitalized patients with chronic kidney disease despite guidelines recommending otherwise.
Shirish Gadgeel, MBBS, reviews the continued positive findings from a clinical trial that combines pembrolizumab with chemotherapy to treat metastatic non-small cell lung cancer.
Yogen Kanthi, MD, finds that blocking an inflammatory molecule, interleukin 1 beta, may help to stop blood clot formation.
With the estimated number of people who have Chronic Kidney Disease (CKD) to be around 37 million , costs estimated to be over $100 billion to treat people with CKD, and more than